13th International Conference on the Molecular Biology and Pathogenesis of Clostridia (ClostPath 13)

摘要 第一次于1995年在亚利桑那州的图斯孔举行，分子生物学和 梭状芽胞杆菌(ClostPath)的发病机制汇集了学术界、临床医生和产业界 科学家。自成立以来，ClostPath会议一直是讨论的热门论坛 关于致病性梭状芽胞杆菌的最新研究和临床发现。过去5-10年 多年来，该领域在引入突变的可靠和简单方法方面取得了快速进展 在其他情况下被认为是基因上难以处理的生物。正因为如此，有 有影响力的研究数量迅速增加，这些研究揭示了 发病机制。此外，随着DNA生成的日益容易 梭状芽胞杆菌的测序、元基因组/微生物组比较导致了新的 假设和新的探索领域。出于这些原因，必须继续执行 传统上是面对面的会面，在亲密的环境中讨论这些发现。ClostPath 13 会议将于2023年9月19日至23日在加拿大班夫举行，将为 传播新思想和新发现。 ClostPath会议将包括一位受邀的主旨演讲人和12位受邀的全体会议 扬声器。每一位受邀的演讲者都将成为其中一场会议的头条新闻：基因调控； 一个健康；-组学；治疗与保健；生理学；微生物组；托尔胡清水讲座； 毒素；孢子；微生物-微生物相互作用；宿主对感染的反应。在每一次会议上， 将从提交的符合会议主题的摘要中选择口头陈述。 摘要的选择将提高初级科学家和来自 根据代表性的人口统计数据，并允许我们的演讲者的不同地理位置。另外， 将选出年轻的科学家来主持每一次会议。这种类型的暴露将使 这些崭露头角的科学家在科学界有更多的曝光率。 ClostPath 13的目标将是继续(I)提供一个场所，以允许 介绍致病性梭状芽胞杆菌的前沿研究；以及(Ii)鼓励 青年科学家和初级教员参加每一次全体会议。这些 目标将得到两个目标的支持：目标1是提供一个支持 培养青年科学家和来自不同人口统计的科学家。目标2是提供一种 促进思想、假设和创新实验的轻松交流的环境 战略。

Summary First held in Tuscon, AZ in 1995, the International Conferences on the Molecular Biology and Pathogenesis of Clostridia (ClostPath) bring together academics, clinicians, and industry scientists. Since its inception, the ClostPath conferences have been a popular forum to discuss the latest research and clinical findings regarding pathogenic Clostridia. Over the past 5 – 10 years, the field has seen a rapid advance in reliable and easy methods to introduce mutations into organisms that were otherwise considered genetically intractable. Because of this, there has been a rapid increase in the number of impactful studies that shed light on the fundamental mechanisms of pathogenesis. Moreover, with the ever-increasing ease of generating DNA sequencing, metagenomic / microbiome comparisons in the Clostridia have led to new hypotheses and new areas of exploration. For these reasons, it is imperative to continue with the tradition of face-to-face meetings to discuss these findings in intimate settings. The ClostPath 13 conference will be held September 19 – 23, 2023 in Banff, Canada and will provide a forum for the dissemination of new ideas and findings. The ClostPath conference will consist of an invited Keynote speaker and 12 invited plenary speakers. Each of the invited speakers will headline one of the sessions on: Gene Regulation; One Health; -omics; Treatments & Healthcare; Physiology; Microbiome; Torhu Shimizu Lecture; Toxins; Spores; Microbe – Microbe Interactions; Host Response to Infection. In each session, there will be oral presentations chosen from submitted abstracts that fit the session topic. Abstracts will be chosen so as to increase the visibility of junior scientists and scientists from under representative demographics and allow for diverse geography of our presenters. Also, Young Scientists will be chosen to moderate each of the sessions. This type of exposure will allow these burgeoning scientists to have an increased exposure in the scientific community. The objectives for the ClostPath 13 will be to continue to (i) provide a venue to allow for the presentation of cutting-edge research on pathogenic Clostridia; and (ii) encourage the participation of young scientists and junior faculty in each of the plenary sessions. These objectives will be supported by two Aims: Aim 1 is to provide an environment that supports the development of young scientists and scientists from diverse demographics. Aim 2 is to provide a setting that promotes the easy exchange of ideas, hypotheses, and innovative experimental strategies.